BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 15095474)

  • 1. Properties of SEPT9 isoforms and the requirement for GTP binding.
    Robertson C; Church SW; Nagar HA; Price J; Hall PA; Russell SE
    J Pathol; 2004 May; 203(1):519-27. PubMed ID: 15095474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SEPT9_v4 expression induces morphological change, increased motility and disturbed polarity.
    Chacko AD; Hyland PL; McDade SS; Hamilton PW; Russell SH; Hall PA
    J Pathol; 2005 Aug; 206(4):458-65. PubMed ID: 15902694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High SEPT9_v1 expression in human breast cancer cells is associated with oncogenic phenotypes.
    Gonzalez ME; Peterson EA; Privette LM; Loffreda-Wren JL; Kalikin LM; Petty EM
    Cancer Res; 2007 Sep; 67(18):8554-64. PubMed ID: 17875694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insights into animal septins using recombinant human septin octamers with distinct SEPT9 isoforms.
    Iv F; Martins CS; Castro-Linares G; Taveneau C; Barbier P; Verdier-Pinard P; Camoin L; Audebert S; Tsai FC; Ramond L; Llewellyn A; Belhabib M; Nakazawa K; Di Cicco A; Vincentelli R; Wenger J; Cabantous S; Koenderink GH; Bertin A; Mavrakis M
    J Cell Sci; 2021 Aug; 134(15):. PubMed ID: 34350965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pathobiology of the septin gene family.
    Hall PA; Russell SE
    J Pathol; 2004 Nov; 204(4):489-505. PubMed ID: 15495264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Up-regulation of SEPT9_v1 stabilizes c-Jun-N-terminal kinase and contributes to its pro-proliferative activity in mammary epithelial cells.
    Gonzalez ME; Makarova O; Peterson EA; Privette LM; Petty EM
    Cell Signal; 2009 Apr; 21(4):477-87. PubMed ID: 19071215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Septin 9 isoform expression, localization and epigenetic changes during human and mouse breast cancer progression.
    Connolly D; Yang Z; Castaldi M; Simmons N; Oktay MH; Coniglio S; Fazzari MJ; Verdier-Pinard P; Montagna C
    Breast Cancer Res; 2011 Aug; 13(4):R76. PubMed ID: 21831286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomic profiling of the oncogenic septin 9 reveals isoform-specific interactions in breast cancer cells.
    Devlin L; Okletey J; Perkins G; Bowen JR; Nakos K; Montagna C; Spiliotis ET
    Proteomics; 2021 Oct; 21(19):e2100155. PubMed ID: 34409731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Translational control of SEPT9 isoforms is perturbed in disease.
    McDade SS; Hall PA; Russell SE
    Hum Mol Genet; 2007 Apr; 16(7):742-52. PubMed ID: 17468182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of a SEPT9 interacting protein, SEPT14, a novel testis-specific septin.
    Peterson EA; Kalikin LM; Steels JD; Estey MP; Trimble WS; Petty EM
    Mamm Genome; 2007 Nov; 18(11):796-807. PubMed ID: 17922164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of the SEPT9_i4 isoform confers resistance to microtubule-interacting drugs.
    Chacko AD; McDade SS; Chanduloy S; Church SW; Kennedy R; Price J; Hall PA; Russell SE
    Cell Oncol (Dordr); 2012 Apr; 35(2):85-93. PubMed ID: 22278362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mammalian SEPT9 isoforms direct microtubule-dependent arrangements of septin core heteromers.
    Sellin ME; Stenmark S; Gullberg M
    Mol Biol Cell; 2012 Nov; 23(21):4242-55. PubMed ID: 22956766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct roles of septins in cytokinesis: SEPT9 mediates midbody abscission.
    Estey MP; Di Ciano-Oliveira C; Froese CD; Bejide MT; Trimble WS
    J Cell Biol; 2010 Nov; 191(4):741-9. PubMed ID: 21059847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multimodality expression profiling shows SEPT9 to be overexpressed in a wide range of human tumours.
    Scott M; Hyland PL; McGregor G; Hillan KJ; Russell SE; Hall PA
    Oncogene; 2005 Jul; 24(29):4688-700. PubMed ID: 15782116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression profiling the human septin gene family.
    Hall PA; Jung K; Hillan KJ; Russell SE
    J Pathol; 2005 Jul; 206(3):269-78. PubMed ID: 15915442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SEPT9_i1 and genomic instability: mechanistic insights and relevance to tumorigenesis.
    Peterson EA; Stanbery L; Li C; Kocak H; Makarova O; Petty EM
    Genes Chromosomes Cancer; 2011 Nov; 50(11):940-9. PubMed ID: 21910160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imaging of hypoxia-inducible factor 1α and septin 9 interaction by bimolecular fluorescence complementation in live cancer cells.
    Golan M; Mabjeesh NJ
    Oncotarget; 2017 May; 8(19):31830-31841. PubMed ID: 28380438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphorylation of a new brain-specific septin, G-septin, by cGMP-dependent protein kinase.
    Xue J; Wang X; Malladi CS; Kinoshita M; Milburn PJ; Lengyel I; Rostas JA; Robinson PJ
    J Biol Chem; 2000 Apr; 275(14):10047-56. PubMed ID: 10744683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Septin 9 amplification and isoform-specific expression in peritumoral and tumor breast tissue.
    Connolly D; Hoang HG; Adler E; Tazearslan C; Simmons N; Bernard VV; Castaldi M; Oktay MH; Montagna C
    Biol Chem; 2014 Feb; 395(2):157-67. PubMed ID: 24127542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Septin 9_i2 is downregulated in tumors, impairs cancer cell migration and alters subnuclear actin filaments.
    Verdier-Pinard P; Salaun D; Bouguenina H; Shimada S; Pophillat M; Audebert S; Agavnian E; Coslet S; Charafe-Jauffret E; Tachibana T; Badache A
    Sci Rep; 2017 Mar; 7():44976. PubMed ID: 28338090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.